Natural Cycles, the company that developed the world’s first birth control app, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its use of wrist temperature data from Apple Watch.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Jardiance (empagliflozin) for the treatment of adults with chronic kidney disease (CKD), Boehringer Ingelheim and Eli Lilly and Company announced.
Ascendis Pharma and Phillips-Medisize Receive Third Award for the SKYTROFA Auto-Injector. his first-of-its-kind product enables convenient and efficient preparation and delivery of SKYTROFA—a vital growth hormone treatment for children.
Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive purchase and licence agreement for a portfolio of preclinical gene therapy programmes and enabling technologies from Pfizer Inc.
The UK pharmaceutical sector is forecast to grow faster than its European peers but prevailing productivity issues could scupper progress, research from business insurer QBE has found.
Bayer AG hosted its Pharmaceuticals R&D Event 2023 for Investors yesterday. The company presented a deep dive on the innovation strategy in its four therapeutic core areas Oncology, Cardiovascular Diseases, Neurology & Rare Diseases and Immunology.
FUJIFILM Corporation today announced that the company has appointed Lars Petersen as the new President and Chief Executive Officer (CEO) of FUJIFILM Diosynth Biotechnologies.
The Public Investment Fund (PIF) today announced the establishment of the Pharmaceutical Investment Company (Lifera), a commercial-scale contract development and manufacturing organisation.
